Hospice Use by Medicare Beneficiaries With HF hospice at lower rates than those with cancer. 19 Furthermore, patients with HF were more likely to enroll in hospice within 3 days of death. 16 Although patients with HF are more likely to use emergency care services and disenroll from hospice than patients with cancer, evidence suggests that there is little difference in caregiver satisfaction by diagnosis. 21 Specifically, family caregivers are equally satisfied with hospice professionals' care for patients with HF and cancer, especially in the area of symptom management. 21 Data specific to patterns of hospice use in the HF population remains limited. 22, 23 To improve our understanding of patients with advanced HF who enroll in hospice, we describe a sample of Medicare beneficiaries with advanced HF, including demographics, patterns of hospice use, and acute medical service utilization (hospital admissions, intensive care unit [ICU] stays, and emergency room [ER] visits) before and after hospice enrollment. By establishing the advantages of hospice to patients with advanced HF, referral patterns could be changed, so more individuals benefit from this model of comprehensive care at the end of life.
Methods

Study Population
In collaboration with the Visiting Nurse Service of New York Center for Home Care Policy and Research, we conducted a secondary analysis using data from a longitudinal, observational study that examined patterns of care in a cohort of HF patients using Medicare claims and patient assessment data. 24 This existing data set used 2009 and 2010 Medicare administrative claims and home health patient assessment data to identify all HF hospitalizations with discharge to home health care (HHC) between July 1, 2009, and June 30, 2010. 24 To identify HF hospitalizations, we included patients admitted with a principal diagnosis of HF using the International Classification of Diseases, Ninth Revision, Clinical Modification codes used by the federal Chronic Conditions Data Warehouse and a medical Medicare Severity Diagnosis Related Group. 24 HF hospitalizations assigned to a surgical Medicare Severity Diagnosis Related Group were excluded because wound care, rather than HF management, was likely the primary reason for care. To examine beneficiaries with advanced HF, we selected a subsample of individuals with ≥2 HF hospitalizations within a 6-month period (July 1, 2009, to December 31, 2009), as a marker of increased HF severity or worse prognosis. 25 Only patients enrolled in hospice after the second HF discharge between July 1, 2009, and December 31, 2009, using follow-up data between January 1, 2010 and December 31, 2010, were included for analysis.
Demographics
We conducted descriptive analyses of the beneficiary demographics. We identified age, sex, and race from the Medicare data. A simple count of the number of comorbidities was our measure of comorbidity burden. By linking beneficiary zip codes to Census data, we obtained the median family income in the patient's area of residence.
Patterns of Hospice Use
To characterize the timing of hospice referral, we calculated (1) number of days from second HF hospitalization discharge to hospice enrollment; (2) number of days from hospice enrollment to death; and (3) number of days from hospice enrollment to disenrollment, for those who disenrolled. We report the median number of days between the second HF hospital discharge and hospice enrollment and the median number of days enrolled in hospice. Hospice disenrollment may be initiated either by the patient or the hospice. 22 Patients may revoke their election of hospice because of dissatisfaction with care, change in preferences for hospice care, or the desire to pursue treatments not covered under the Medicare Hospice Benefit. A hospice may discharge a patient if the hospice deems the patient no longer eligible for hospice, the patient moves out of the hospice's service area, or the hospice can no longer safely provide care. We identified hospice disenrollment as a condition code of patient discharged for cause or patient status code of discharge to home, revoked, or decertified on their last Medicare hospice claim. Finally, we examined the location of death using the place of service for those enrolled in hospice on their last Medicare hospice claim and for those not enrolled in hospice on their last Medicare claim.
Acute Medical Service Utilization: Hospital Admissions, ICU Stays, and ER Visits
Hospital admissions, ICU stays, and ER visits that ended in hospital admission were identified from the Medicare Provider Analysis and Review file, whereas ER visits that did not end in hospital admission were identified from Medicare Outpatient Standard Analytic files. Because individual beneficiaries died at different time points after hospice enrollment, we used population-averaged generalized estimating equations negative binomial models, also known as panel-negative binomial models, 26 to account for differences in length of exposure and possible correlation between the before and after measurements for the same patients, when calculating acute medical service utilization 6 months before and after hospice enrollment. We calculated unadjusted and adjusted marginal means of the number of hospital admissions, ICU stays, and ER visits and compared the differences in means before and after enrollment. We used Stata 12 to estimate these models.
The Visiting Nurse Service of New York Center for Home Care Policy and Research and the Icahn School of Medicine at Mount Sinai institutional review boards approved conduct of this study. Table 1 . The mean age of beneficiaries was 82 years at the time of death, 55% were female, and 87% were white non-Hispanic. The mean comorbidity count was 2.38 (SD of 1.22 with a range of 0-6), and 45% had a mean comorbidity count of ≥3.
Results
Demographics
Patterns of Hospice Use
The median and mean number of days from second HF hospital discharge to enrollment in hospice was 45 days and 70 days, respectively (SD of 73 days; Figure 2 ). Figure 2 also shows 24% of our sample enrolling in hospice within 0 to 7 days after second HF hospital discharge and another 23% enrolling ≤91 to 180 days after second HF hospital discharge. The mean number of days from hospice enrollment to death was 71 days (SD of 112 days; Figure 3) . Half of the patients died after 16 days of hospice care and 39% died within 7 days (Figure 4) . Four hundred and fifty-four individuals (8.9%) were still alive at 1 year after hospice enrollment. Five hundred and fifty-five beneficiaries (11%) disenrolled from hospice at least once in the 1 year after hospice enrollment. Of those, 38% disenrolled in the first 30 days after hospice enrollment.
By the end of the study period, 4619 beneficiaries (91%) had died. Of those, 4051 beneficiaries (88%) died while enrolled in hospice. Of the 568 beneficiaries who disenrolled from hospice and died while not receiving hospice care, 48.6% died in an acute hospital facility, 17.6% died in a skilled nursing facility or rehabilitation center, 2% died receiving HHC, and 31.9% died outside of these settings of care. 
Acute Medical Service Utilization: Hospital Admissions, ICU Stays, and ER Visits
Discussion
We describe the demographics, patterns of hospice use, and acute medical service utilization in the 6 months before and after hospice enrollment for Medicare beneficiaries with advanced HF. We aimed to focus on the benefits to HF patients once they are enrolled in hospice. Specifically, we were interested in describing the trajectory of patients with HF enrolled in hospice, rather than describing their hospice enrollment patterns, so we only studied the sample that enrolled in hospice (N=5073 from Figure 1) .
Demographics of this sample of older adults with HF who used hospice-45% were ≥85 years of age, a slight majority were female, and 87% were white-are similar to national trends regarding characteristics of hospice users across all diagnoses. 10 In addition, although advanced HF patients are referred to hospice less often, this sample's time to hospice enrollment, high prevalence of short hospice enrollment periods, and hospice disenrollment rate of this sample parallel that of hospice users across all diagnoses nationally. 
Time to Referral to Hospice
Earlier referral to hospice has been demonstrated to improve the quality of end-of-life care received by patients and their families. 11 Patients may not receive the full benefit of hospice services when enrollment periods are ≤1 week, and this has been associated with poor outcomes for patients and their families. [27] [28] [29] [30] A study by the US Department of Health and Human Services suggests that a patient must receive hospice care for at least 30 days to minimally experience its benefits. 31 Timing of referral is challenging because of the unpredictable clinical course of patients with HF. Additionally, stage D patients are potential candidates for advanced therapies. 32 The bimodal distribution of days until hospice enrollment after second HF hospital discharge (Figure 2 ) may reflect the clinical trajectory of HF. 33, 34 The later peak in hospice enrollment may be because of patients who initially return to their clinical baseline and later experienced a clinical decline.
Given that 39% of the beneficiaries in our sample died within 7 days of hospice enrollment and half died within 16 days, this population may be referred to hospice too late. This duration of hospice enrollment is comparable to national trends: 32.4% of all Medicare decedents in 2011 used hospice for <7 days. 35 Similar to other seriously ill patients, patients with advanced HF could benefit from earlier hospice enrollment and, therefore, receive improved symptom control. The barriers to earlier hospice referral in this population remain unstudied. With earlier hospice referral, advanced HF patients would receive the beneficial effects of hospice.
The unpredictable trajectory of HF makes prognostication challenging, leading to variable hospice enrollment periods (short enrollment [≤1 week] versus long enrollment period [>6 months]). 22 In our sample, 281 beneficiaries (5.54%) had a long enrollment period compared with 10.3% reported in the National Hospice and Palliative Care Organization 10 and 13.9% in Medicare hospice claims.
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Rates of Hospice Disenrollment
Another opportunity to improve the quality of hospice care received by patients with advanced HF would be reducing the rate of hospice disenrollment, which impacts quality of care received, healthcare utilization, and cost. Eleven percent of the beneficiaries in our sample disenrolled at least once after hospice enrollment, which is comparable to other reports on hospice disenrollment. [36] [37] [38] In patients with cancer, hospice disenrollment is associated with higher healthcare use, including higher rates of hospitalization, ED and ICU admissions, and increased length of stay once hospitalized. 38 On average, patients with advanced cancer who disenroll cost Medicare almost 5 times as much as those who remain with hospice until death. 37 Additionally, disenrollees were more likely to die in the hospital. 37, 38 In our sample, of those who died, 88% died while receiving hospice care, which is consistent with patient preferences for death. 2 Of the 568 beneficiaries (11%) who died without hospice care, nearly half died in an acute hospital facility, and 17.6% died in a skilled nursing facility or rehabilitation center, which is inconsistent with data on patient and caregiver preferences.
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Acute Medical Service Utilization Before and After Hospice Enrollment
We found that the mean number of hospital admissions, ICU admissions, and ER visits all decreased after hospice enrollment, consistent with other populations. 40 These findings are significant because there is a growing body of literature demonstrating an increase in acute medical service utilization as HF clinical trajectory progresses and symptom burden worsens. 34, [41] [42] [43] In addition, these findings are timely given the policy efforts to reduce HF readmission rates and healthcare costs; if eligible patients are referred to hospice, significant reductions in cost and utilization are possible.
Limitations
Our study population includes only Medicare beneficiaries who received HHC before the 2 HF hospitalizations, so this sample may not be generalizable to other populations. In spite of this limitation, patients who required HHC are likely to have a more severe illness course and thus have greater need for skilled services such as those provided by hospice. However, patients receiving HHC, by virtue of having an informal home caregiver, may have both a better social safety net and function, thereby preventing admission to a skilled nursing facility.
Additionally, HHC agencies with embedded hospice services may have different referral patterns than those without, and this was a difference we could not account for. There is a potential threat to external validity of the study given the overlap of our inclusion criteria of ≥2 HF hospitalizations and the outcome variable of hospital admissions.
Another limitation is in how we categorized those who disenrolled from hospice. Because Medicare claims data does not include information about patient preferences, we are unable to distinguish those who disenrolled from hospice because of improved clinical stability from those who disenrolled because of change in treatment preference for hospice. Finally, without standard HF severity indicators, such as HF stage or New York Heart Association HF class, we examined only those with at least 2 HF hospitalizations within a 6-month period as a surrogate for disease severity.
Conclusions
This sample of HHC Medicare beneficiaries with advanced HF who enroll in hospice reflects the national trends in hospice enrollment across all diagnoses. The clinical marker of 2 HF hospitalizations within a 6-month period could serve as an opportunity to initiate earlier conversations about advance care planning and hospice enrollment. These results highlight the need for timelier hospice referral in this population, thereby allowing for longer enrollment periods and decreased disenrollment rates; in turn, patients with advanced HF and their families would benefit from the spectrum of hospice services and improved quality of endof-life care. Ultimately, further research is necessary, so we can better tailor hospice to the needs of older adults with advanced HF. The core data set analyzed in this study was developed as part of a project supported by grant number R01HS020257 from the Agency for Healthcare Research and Quality.
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